 AML is treated initially with chemotherapy aimed at inducing a remission ; people may go on to receive additional chemotherapy or a <unk> stem cell transplant . Recent research into the genetics of AML has resulted in the availability of tests that can predict which drug or drugs may work best for a particular person , as well as how long that person is likely to survive . The treatment and prognosis of AML differ from those of chronic <unk> leukemia ( <unk> ) in part because the cellular differentiation is not the same ; AML involves higher percentages of <unk> and undifferentiated cells , including more blasts ( <unk> , <unk> , and <unk> ) . 
